Edex

Edex is a brand name of alprostadil, approved by the FDA in the following formulation(s):

EDEX (alprostadil - injectable; injection)

• 
  Manufacturer: SCHWARZ PHARMA
  
  Approval date: June 12, 1997
  
  Strength(s): 0.01MG/VIAL ^[AP], 0.02MG/VIAL ^[AP], 0.04MG/VIAL ^[RLD][AP]


• 
  Manufacturer: SCHWARZ PHARMA
  
  Approval date: July 30, 1998
  
  Strength(s): 0.01MG/VIAL ^[RLD], 0.02MG/VIAL ^[RLD], 0.04MG/VIAL ^[RLD]

Has a generic version of Edex been approved?

Yes. The following products are equivalent to Edex:

CAVERJECT (alprostadil injectable; injection)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: July 6, 1995
  
  Strength(s): 0.01MG/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Edex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Edex.

See also...

• Edex Consumer Information (Wolters Kluwer)
• Edex injectable and transurethral Consumer Information (Cerner Multum)
• Edex Advanced Consumer Information (Micromedex)
• Alprostadil Consumer Information (Wolters Kluwer)
• Alprostadil Suppository Consumer Information (Wolters Kluwer)
• Alprostadil injectable and transurethral Consumer Information (Cerner Multum)
• Muse Micro Advanced Consumer Information (Micromedex)
• Alprostadil Intraurethral, Intravenous, Intracavernosal Advanced Consumer Information (Micromedex)
• Alprostadil AHFS DI Monographs (ASHP)